The University of Chicago Header Logo

Connection

Siri Atma W. Greeley to Diabetes Mellitus

Back to Details
This is a "connection" page, showing publications Siri Atma W. Greeley has written about Diabetes Mellitus.
Siri Atma W. Greeley
Connection Strength
7.650
Diabetes Mellitus
  1. Clinical Characteristics and Remission Monitoring of 6q24-Related Transient Neonatal Diabetes. Pediatr Diabetes. 2024; 2024:3624339.
    View in: PubMed
    Score: 0.541
  2. Growth and development in monogenic forms of neonatal diabetes. Curr Opin Endocrinol Diabetes Obes. 2022 02 01; 29(1):65-77.
    View in: PubMed
    Score: 0.445
  3. Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations. Curr Diab Rep. 2019 06 27; 19(8):52.
    View in: PubMed
    Score: 0.372
  4. Monogenic diabetes: the impact of making the right diagnosis. Curr Opin Pediatr. 2018 08; 30(4):558-567.
    View in: PubMed
    Score: 0.349
  5. Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features. Curr Diab Rep. 2018 06 13; 18(7):46.
    View in: PubMed
    Score: 0.346
  6. Precision medicine in KCNJ11 permanent neonatal diabetes. Lancet Diabetes Endocrinol. 2018 08; 6(8):594-595.
    View in: PubMed
    Score: 0.345
  7. Congenital forms of diabetes: the beta-cell and beyond. Curr Opin Genet Dev. 2018 06; 50:25-34.
    View in: PubMed
    Score: 0.338
  8. Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA. J Clin Endocrinol Metab. 2018 01 01; 103(1):35-45.
    View in: PubMed
    Score: 0.335
  9. Neonatal Diabetes Mellitus: An Update on Diagnosis and Management. Clin Perinatol. 2018 03; 45(1):41-59.
    View in: PubMed
    Score: 0.334
  10. Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures. Pediatr Diabetes. 2018 05; 19(3):393-397.
    View in: PubMed
    Score: 0.334
  11. Preservation of Reduced Numbers of Insulin-Positive Cells in Sulfonylurea-Unresponsive KCNJ11-Related Diabetes. J Clin Endocrinol Metab. 2017 01 01; 102(1):1-5.
    View in: PubMed
    Score: 0.313
  12. Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls. Diabet Med. 2016 10; 33(10):1380-6.
    View in: PubMed
    Score: 0.302
  13. An online monogenic diabetes discussion group: supporting families and fueling new research. Transl Res. 2015 Nov; 166(5):425-31.
    View in: PubMed
    Score: 0.282
  14. Continued lessons from the INS gene: an intronic mutation causing diabetes through a novel mechanism. J Med Genet. 2015 Sep; 52(9):612-6.
    View in: PubMed
    Score: 0.281
  15. Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation. Diabetes Care. 2013 Dec; 36(12):e201.
    View in: PubMed
    Score: 0.253
  16. Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder. Pediatr Diabetes. 2014 May; 15(3):252-6.
    View in: PubMed
    Score: 0.251
  17. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep. 2011 Dec; 11(6):519-32.
    View in: PubMed
    Score: 0.220
  18. Creation of the Web-based University of Chicago Monogenic Diabetes Registry: using technology to facilitate longitudinal study of rare subtypes of diabetes. J Diabetes Sci Technol. 2011 Jul 01; 5(4):879-86.
    View in: PubMed
    Score: 0.214
  19. The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011 Mar; 34(3):622-7.
    View in: PubMed
    Score: 0.208
  20. Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrinol Metab. 2010 Aug; 21(8):464-72.
    View in: PubMed
    Score: 0.197
  21. Smaller Pancreas Volume in Insulin-Dependent Monogenic Diabetes. Diabetes. 2025 Aug 01; 74(8):1411-1416.
    View in: PubMed
    Score: 0.142
  22. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat Med. 2023 10; 29(10):2438-2457.
    View in: PubMed
    Score: 0.125
  23. Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care. 2020 12; 43(12):3117-3128.
    View in: PubMed
    Score: 0.103
  24. Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes. Diabetes Care. 2021 01; 44(1):35-42.
    View in: PubMed
    Score: 0.102
  25. Update of variants identified in the pancreatic ß-cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes. Hum Mutat. 2020 05; 41(5):884-905.
    View in: PubMed
    Score: 0.097
  26. Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated. Diabetes. 2019 07; 68(7):1528-1535.
    View in: PubMed
    Score: 0.092
  27. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2018 10; 19 Suppl 27:47-63.
    View in: PubMed
    Score: 0.088
  28. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Diabetes. 2018 05; 19(3):388-392.
    View in: PubMed
    Score: 0.083
  29. ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes. Pediatr Diabetes. 2017 Nov; 18(7):518-523.
    View in: PubMed
    Score: 0.076
  30. Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes. Diabetologia. 2015 Jul; 58(7):1430-5.
    View in: PubMed
    Score: 0.069
  31. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol Genet Metab. 2014 Dec; 113(4):315-320.
    View in: PubMed
    Score: 0.067
  32. Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype. Diabetologia. 2013 Jan; 56(1):218-21.
    View in: PubMed
    Score: 0.059
  33. Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas. Diabetes Care. 2012 Oct; 35(10):2086-8.
    View in: PubMed
    Score: 0.058
  34. Onset features and subsequent clinical evolution of childhood diabetes over several years. Pediatr Diabetes. 2011 Jun; 12(4 Pt 1):326-34.
    View in: PubMed
    Score: 0.052
  35. HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes. Pediatr Diabetes. 2011 Jun; 12(4 Pt 2):388-95.
    View in: PubMed
    Score: 0.052
  36. Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect. Diabetes Care. 2009 Aug; 32(8):1428-30.
    View in: PubMed
    Score: 0.046
  37. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A. 2007 Sep 18; 104(38):15040-4.
    View in: PubMed
    Score: 0.041
  38. Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes. Sci Rep. 2021 11 03; 11(1):21590.
    View in: PubMed
    Score: 0.027
  39. NOD B-cells are insufficient to incite T-cell-mediated anti-islet autoimmunity. Diabetes. 2005 Jul; 54(7):2019-25.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.